Featured Firms
Presented by BigVoodoo
A drug company is a private figure for the purpose of a defamation case even though it received federal funding and was subject to peer review articles, a Philadelphia common pleas court judge ruled. Delaware-based Hemispherx Biopharma sued investment firm Asensio & Co. for allegedly making defamatory statements in press releases and research reports to "illegally manipulate" the price of and short-sell HBI's stock.
September 17, 2001 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS